KARE will use Affymetrix’ SNP Array 5.0 to generate genotypes from 10,000 samples.

Republic of Korea’s NIH (KNIH) and Center for Disease Control and Prevention will use the Affymetrix Genome-Wide Human SNP Array 5.0 for the Korean Association REsource (KARE) project. This genome-wide association study is designed to identify the genetic causes of lifestyle-related complex diseases that are prevalent in Korea.

“Using the new Affymetrix SNP Array 5.0, we will be able to perform a true, unbiased genome-wide association study,” notes Bermseok Oh, Ph.D., chief, division of structural and functional genomics at KNIH.

The KARE project will use the Affymetrix tool to generate individual genotypes from more than 10,000 human DNA samples. The resulting information will be made available as part of a database to aid dditional research projects. The program will use samples from the prospective epidemiological Ansan and Ansung cohorts in Korea.

The Affymetrix microarrays will be run in the high-throughput lab of DNA Link, an Affymetrix-certified service provider in Korea. SeouLin Bioscience will also provide technical support to the KNIH.

Previous articleJacobs Receives Wyeth Contract for PLX Pilot Laboratory Facility
Next articleLonza to Spend More Than $64M in Manufacturing Site Expansion